Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
13195-64-7
20605-01-0
5471-77-2
623-72-3
6148-64-7
42726-73-8
1909223-02-4 | TAMRA-PEG4-acid | AA019ED6 | MFCD31536753
2183440-71-1 | Cy7 bis-NHS ester | AA019EH1
1956319-30-4 | 2-(6-Azaspiro[2.5]octan-1-yl)ethanol hydrochloride | AA019EKA | MFCD28390321
94654-52-1 | 3-bromobiphenyl-2-carboxylic acid | AA019EN9 | MFCD31652774
1715031-89-2 | tert-Butyl 4-(3-amino-6-bromopyrazin-2-yl)-2-fluorobenzoate | AA019EQG | MFCD28991984
1642303-04-5 | (3S)-2-(4-Bromo-2-fluorobenzyl)-3-methyl-6-phenyl-1,2-thiazinane 1,1-dioxide | AA019ETL | MFCD30185794
20940-75-4 | 2-(3-methoxybenzyl)succinic acid | AA019EWY | MFCD00582472
1120334-30-6 | ethyl 7-nitro-2-phenyl-1H-indole-5-carboxylate | AA019EZV | MFCD31652813
959122-11-3 | A 922500 | AA019FVD | MFCD12828780
328028-11-1 | 3-[(2-fluorophenyl)sulfamoyl]benzoic acid | AA019GFI | MFCD02704605